IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
35.08
+1.89 (5.69%)
At close: Mar 9, 2026, 4:00 PM EDT
35.61
+0.53 (1.51%)
After-hours: Mar 9, 2026, 7:57 PM EDT

IDEAYA Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
-113.7-274.48-112.96-58.66-49.76
Upgrade
Depreciation & Amortization
4.593.834.013.523.03
Upgrade
Loss (Gain) From Sale of Investments
-9.98-23.23-11.55-0.71.83
Upgrade
Stock-Based Compensation
46.1234.7518.4911.638.24
Upgrade
Change in Accounts Receivable
-5.97--13.560.890.77
Upgrade
Change in Accounts Payable
2.78.282.641.861.17
Upgrade
Change in Unearned Revenue
----46.48-23.54
Upgrade
Change in Other Net Operating Assets
5.143.27-2.280.752.48
Upgrade
Operating Cash Flow
-71.1-247.58-115.22-87.18-55.78
Upgrade
Capital Expenditures
-2.37-3.86-2.37-3.44-2.64
Upgrade
Investment in Securities
72.34-498.7-156.09-29.96-67.02
Upgrade
Investing Cash Flow
69.98-502.56-158.46-33.4-69.67
Upgrade
Issuance of Common Stock
29.78668.15320.5497.17145.45
Upgrade
Other Financing Activities
-9.442.18--
Upgrade
Financing Cash Flow
29.78677.55362.7297.17145.45
Upgrade
Net Cash Flow
28.66-72.5989.04-23.4120.01
Upgrade
Free Cash Flow
-73.47-251.44-117.59-90.62-58.42
Upgrade
Free Cash Flow Margin
-33.59%-3592.01%-502.85%-177.92%-209.09%
Upgrade
Free Cash Flow Per Share
-0.83-3.08-2.04-2.19-1.66
Upgrade
Cash Interest Paid
-0.030.070.060.07
Upgrade
Cash Income Tax Paid
----0
Upgrade
Levered Free Cash Flow
-52.47-155.09-70.28-42.37-15.64
Upgrade
Unlevered Free Cash Flow
-52.47-155.09-70.28-42.37-15.64
Upgrade
Change in Working Capital
1.8711.55-13.21-42.97-19.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.